NCT03368807View on ClinicalTrials.gov

Assessment of Mealtime Bolus Insulin Behavior

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

June 12, 2018

Study Completion Date

July 23, 2018

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

Continuous Glucose Monitoring

Commercially available

DRUG

Insulin Lispro

As prescribed.

Trial Locations (6)

50265

Iowa Diabetes & Endocrinology Research Center, West Des Moines

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

84405

Advanced Research Institute, Ogden

90045

Science 37 Inc, Los Angeles

92025

AMCR Institute, Inc., Escondido

93003

Coastal Metabolic Research Ctr, Ventura

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03368807 - Assessment of Mealtime Bolus Insulin Behavior | Biotech Hunter | Biotech Hunter